Cannabis stocks – struggling to get high

Cannabis stocks – struggling to get high
Greenfern will soon start writing clinical trial protocols for a low dose cannabidiol medication. (Image: Getty)
Brian Gaynor
The three NZX-listed cannabis companies – Cannasouth, Greenfern Industries and Rua Bioscience – are struggling to gain momentum, particularly as far as their share price performances are concerned.All three stocks are trading well below their issue price.This will be a major disappointment to Sharesies investors because they have dominated trading activity in all three companies.Sharesies investors make up 61% of all Cannasouth on-market trades by number since listing, 70.5% of Greenfern’s trades, and 64.3% of Rua Bioscience&r...

More Opinion

The future of news: yet another reckon
Opinion

Pattrick Smellie: The future of news: yet another reckon

News needs to define itself by being worth paying for.

On valuations, models and moving targets
Opinion

Simon Robertson: On valuations, models and moving targets

My future and ‘forward-looking’ valuations are a combination of many things.

Simon Robertson 26 Apr 2025
Google monopoly breach evens media playing field
Opinion

Jane Ormsby: Google monopoly breach evens media playing field

Optimism remains in getting transparency and increased regulation for the industry.

Jane Ormsby 24 Apr 2025
Tricks of the traders revealed
Opinion

David Chaplin: Tricks of the traders revealed

The UK regulator probably has more power to enforce trading app trickery than in NZ.

David Chaplin 23 Apr 2025